Back
30 December 2024

Embedded Expertise: Pioneering a Radiopharmaceutical Services Model

Written by Bracken

The Scenario

Biotech company CytoSite Bio was developing a novel diagnostic radiopharmaceutical (a Granzyme B imaging agent) and recognized the agent’s significant scalability and potential for applications beyond its original purpose.

They wanted to evaluate the agent's potential as a companion diagnostic in immuno-oncology.

To achieve this, CytoSite sought out expert guidance to navigate the complex regulatory, clinical, and business challenges....

RECENT CASE STUDIES

The Data Most Companies Throw Away: How a Reconstruction Workflow Can Help Save a Clinical Trial

The Scenario Most sites discard the richest data a PET scanner produces; list mode data is usually..

Embedding Patient Engagement into Clinical Development

The Scenario A global, mid-sized biopharmaceutical company had made PFDD a strategic priority and..